FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Rivastigmine Tartrate (Exelon) Capsules
Status: Discontinuation
»Therapeutic Categories: Neurology

Expand all

Novartis (New 12/02/2015)

Company Contact Information:
888-669-6682

Presentation Posting Date Related Information
1.5 mg Bottle of 60 (NDC 0078-0323-44) 12/02/2015 Novartis plans to make the inventory available to wholesalers till 9 months from expiry date, Aug 2017 of last manufactured batch. The decision to discontinue this product is business-related and not based on efficacy or safety findings.
3 mg Bottle of 60 (NDC 0078-0324-44) 12/02/2015 Novartis plans to make the inventory available to wholesalers till 9 months from expiry date, Jun 2017 of last manufactured batch. The decision to discontinue this product is business-related and not based on efficacy or safety findings.
4.5 mg Bottle of 60 (NDC 0078-0325-44) 12/02/2015 Novartis plans to make the inventory available to wholesalers till 9 months from expiry date, Jan 2017 of last manufactured batch. The decision to discontinue this product is business-related and not based on efficacy or safety findings.
6 mg Bottle of 60 (NDC 0078-0326-44) 12/02/2015 Novartis plans to make the inventory available to wholesalers till 9 months from expiry date, Apr 2017 of last manufactured batch. The decision to discontinue this product is business-related and not based on efficacy or safety findings.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English